XML 49 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Tables)
3 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Segment financial information
    Three months Ended September 30,
    2020   2019
 Consolidated revenue:                
 Aytu BioScience   $ 5,752,000     $ 1,440,000  
 Aytu Consumer Health     7,768,000       —    
 Consolidated revenue     13,520,000       1,440,000  
                 
 Consolidated net loss:                
 Aytu BioScience     (2,950,000 )     (4,929,000 )
 Aytu Consumer Health     (1,356,000 )     —    
 Consolidated net loss     (4,306,000 )     (4,929,000 )

 

    As of   As of
    September 30,   June 30,
    2020   2020
 Total assets:                
 Aytu BioScience   $ 116,499,000     $ 126,267,000  
 Aytu Consumer Health     24,772,000       26,569,000  
 Total assets   $ 141,271,000     $ 152,836,000